Tissue repair implants and compositions and methods of implantation
By combining a multi-layered repair implant with biological and synthetic layers, the problems of mechanical property mismatch and unstable fixation in soft tissue-to-bone interface repair in existing technologies are solved, achieving immediate mechanical strength and biologically induced healing effects, and reducing the re-tear rate.
Patent Information
- Application Number
- CN202410778025.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2020-06-16
- Filing Date
- 2021-03-11
- Publication Date
- 2024-11-12
AI Technical Summary
Existing technologies are insufficient to effectively repair the interface between soft tissues and bone, such as the rotator cuff or hip joint capsule. In particular, due to the mismatch in mechanical properties of biological tissue scaffolds and unstable suture fixation, the re-tear rate is high, making it difficult to provide immediate mechanical strength and biologically induced healing.
A multi-layer repair implant combining a biological layer and a synthetic layer is used. The biological layer is composed of collagen, and the synthetic layer is formed of high-strength materials. It is fixed by chemical modification and suturing techniques to increase the mechanical strength and biologically induced healing capacity of the soft tissue-to-bone interface.
It provides immediate mechanical strength, promotes healing of the soft tissue-to-bone interface, reduces the rate of re-tearing, and improves the success rate of repair and the functional recovery of tissues.
Smart Images

Figure CN118924951A_ABST
Abstract
Description
This case is a divisional application of invention patent application number 202180034163.X CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of and priority to U.S. Provisional Patent Application Serial No. 62 / 988,635, filed on March 12, 2020, and entitled Tissue Repair Implants and Methods of Implantation, and U.S. Provisional Patent Application Serial No. 63 / 039,481, filed on June 16, 2020, and entitled Compositions and Methods for Soft Tissue to Bone Repair, the disclosures of which are incorporated herein by reference. Technical Field
[0002] The present invention generally but not in a limiting manner relates to orthopedic implants, compositions and methods of treatment. More particularly, the present invention relates to a tendon / ligament repair implant, such as an implant designed to be placed in a torn or damaged area of a tendon or ligament, and compositions and methods for promoting and enhancing healing at the soft tissue to bone interface in surgical repair. Background Art
[0003] A common soft tissue injury is that of the rotator cuff or rotator cuff tendon due to its complexity, range of motion, and widespread use. Rotator cuff injuries are a potentially serious condition that can occur with hyperextension, acute traumatic tearing, or overuse of the joint. Large to massive rotator cuff tears remain a challenge for surgeons, especially when the tissue to be repaired or reapproximated to its natural position is degenerated. Patient age, tear size, and tendon retraction can all contribute to difficult repairs. Outcomes can be poor, with re-tear rates ranging from about 40% to about 90%.
[0004] Biological tissue scaffolds (e.g., autologous grafts, allografts, xenografts, etc.) can be used to strengthen degenerated tendons in these challenging repairs. Autologous grafts require the sacrifice of functional tissue, and allografts or xenografts may be the preferred solution in general. Most of these biological tissue scaffolds can support natural tissue ingrowth and replacement unless the scaffold is too dense or excessively chemically altered. Allografts and / or xenograft scaffolds may be convenient (e.g., readily available), but may be limited because they do not match the mechanical properties of natural tendons and are therefore not suitable for critical "bridging" indications, where the tendon is severely retracted and needs to be bridged to the gap of the bone.
[0005] Some rotator cuff tears are irreparable. An alternative technique is superior capsule reconstruction (SCR), which utilizes the biologic tissue scaffold described above to stabilize the joint by attaching the glenoid directly to the humeral head. Again, allografts and xenograft scaffolds can be used with this technique because they are convenient, but again they do not have adequate mechanical properties. Allografts and / or xenograft scaffolds are typically attached and secured using conventional sutures, and this fixation is often a weak point in the repair because high-strength synthetic sutures can cause the biologic tissue to split. Synthetic scaffolds have been used for both rotator cuff repair and superior capsule reconstruction, but have not been widely accepted, and more biologically acceptable materials are preferred.
[0006] Other tendons or ligaments in the body, such as but not limited to the hip capsule may also be difficult to repair. The hip capsule is a high-strength tissue in the human body that surrounds the ball and socket joint space of the hip. It is high-strength in part due to the forces it withstands during various ranges of motion of the hip. In order to perform endoscopic hip surgery, the hip capsule is routinely cut open. At the end of the hip arthroscopy, it is desired to repair the capsule. Although the use of a xenograft (or other) scaffold can promote healing of the tissue, the scaffold can be a non-structural implant that is prone to tearing under load. In some cases, there may not be enough hip capsule to adequately repair the structure.
[0007] It may be desirable to include bioinductive implants that include synthetic and biological layers and / or are reinforced with mechanical based structures.
[0008] In addition, during arthroscopic surgery, suture anchors are generally used to reapproximate soft tissue (such as tendons or ligaments) back to the bone surface, thereby promoting the natural healing process of restoring the interface of tendons / ligaments to bones in suture-based repair. The healing of tendons / ligaments to bones involves the formation of new tissues, which are mineralized over time with a gradient from soft tissue to bone, thereby forming a transition zone whose function is to transfer mechanical forces from one tissue type to another. Both calcium ions and phosphate ions are necessary for mineralization, and it is reported that mineralization in tissues (such as those found in the interface of tendons / ligaments to bones) is enhanced. Therefore, it is desirable to increase the amount of calcium and / or phosphate ions available for the repair of soft tissue to bones to promote the reattachment of soft tissue to bones. Summary of the invention
[0009] According to aspects of the present invention, there is provided a tissue repair implant and / or scaffold that combines the benefits of a bioinductive implant that biologically enhances the repaired tendon and improves healing, wherein the implant provides mechanical reinforcement for increased strength.
[0010] An exemplary repair implant includes a sheet-like first component and a second component, wherein a first side surface of the second component is disposed on the first component. The first component includes a biological layer. The second component includes a synthetic material and a plurality of holes.
[0011] Additionally or alternatively, the biolayer is bioresorbable.
[0012] Additionally or alternatively, the repair implant further comprises low molecular weight collagen disposed within the pores of the second component.
[0013] Additionally or alternatively, the repair implant further comprises a third component comprising the biological layer and positioned on a second side surface of the second component, the second side surface being opposite to the first side surface.
[0014] Additionally or alternatively, the second component comprises one or more strands forming a fabric.
[0015] Additionally or alternatively, the prosthetic implant further comprises one or more rings extending generally orthogonally to the plane of the second component.
[0016] Additionally or alternatively, the one or more rings are configured to be attached to the sheet-like first component.
[0017] Additionally or alternatively, a surface of the second component in contact with the first component is chemically modified to covalently bond the first component and the second component.
[0018] Additionally or alternatively, a surface of the second component in contact with the first component is chemically modified to ionically bond the first component to the second component.
[0019] Additionally or alternatively, the second component comprises one or more strands forming a tear-stop pattern.
[0020] Additionally or alternatively, the sheet-like first component comprises collagen.
[0021] Additionally or alternatively, the second component comprises a generally solid layer and the plurality of holes are mechanically introduced.
[0022] Additionally or alternatively, the synthetic material is a non-absorbable polyester.
[0023] Additionally or alternatively, the synthetic material is ultra high molecular weight (UHMW) polyethylene.
[0024] Additionally or alternatively, the first component and the second component are sewn together.
[0025] Another exemplary repair implant includes a sheet-shaped first component and a second component, the second component having a first side surface disposed on the first component. The sheet-shaped first component includes a biological layer. The second component includes a lattice structure.
[0026] Additionally or alternatively, the lattice structure is at least partially formed from a bioabsorbable material.
[0027] Additionally or alternatively, the lattice structure is at least partially formed from a non-bioresorbable material.
[0028] Additionally or alternatively, the lattice structure is at least partially formed from a non-bioresorbable material.
[0029] Additionally or alternatively, the repair implant further comprises a third component comprising the biological layer and positioned on a second side surface of the second component, the second side surface being opposite to the first side surface.
[0030] Additionally or alternatively, the biolayer is bioresorbable.
[0031] Additionally or alternatively, the second component is mechanically coupled to the first component.
[0032] Additionally or alternatively, the biological layer comprises collagen.
[0033] Additionally or alternatively, the bioabsorbable material of the lattice structure comprises collagen.
[0034] Additionally or alternatively, the bioabsorbable material of the lattice structure comprises polylactic acid.
[0035] Additionally or alternatively, the second component is 3D printed.
[0036] Additionally or alternatively, the second component is injection moulded.
[0037] Additionally or alternatively, the grid structure comprises material formed into a pattern of interconnected diamonds.
[0038] Additionally or alternatively, the grid structure further comprises one or more border lines extending around the perimeter of the pattern of interconnected diamonds.
[0039] Additionally or alternatively, the grid structure comprises a plurality of cross-hatched ropes.
[0040] Additionally or alternatively, the lattice structure comprises a first plurality of zigzag ropes and a second plurality of zigzag ropes. The second plurality of zigzag ropes at least partially overlaps the first plurality of zigzag ropes.
[0041] Additionally or alternatively, the grid structure comprises a plurality of interconnected circles.
[0042] Another exemplary repair implant includes a sheet-like first component and reinforcing strands interwoven into the first component.The first component includes a biological layer.
[0043] Additionally or alternatively, the biolayer is bioresorbable.
[0044] Additionally or alternatively, the reinforcing strand is a different colour than the first component.
[0045] Additionally or alternatively, the stitching pattern of the reinforcing strands changes geometry along the length and / or width of the repair implant.
[0046] Additionally or alternatively, the reinforcement strands include sutures.
[0047] Additionally or alternatively, the reinforcing strands are interwoven in a direction extending generally parallel to the longitudinal dimension of the sheet-like first component.
[0048] Additionally or alternatively, the reinforcing strands are interwoven in a direction extending generally orthogonally to the longitudinal dimension of the sheet-like first component.
[0049] Additionally or alternatively, the reinforcing strands are interwoven in a direction extending generally non-orthogonally to the longitudinal dimension of the sheet-like first component.
[0050] Additionally or alternatively, the reinforcing strands are interwoven in two or more directions relative to the longitudinal dimension of the sheet-like first component.
[0051] Additionally or alternatively, the reinforcing strands extend through the thickness of the sheet-like first component.
[0052] Additionally or alternatively, the reinforcing strands extend partially through the thickness of the sheet-like first component.
[0053] Additionally or alternatively, the repair implant further comprises one or more rings within the edge of the sheet-like first component or outside the edge of the sheet-like component.
[0054] Additionally or alternatively, the one or more rings are configured to support attachment of the prosthetic implant to a natural structure.
[0055] Another exemplary repair implant may include a plurality of high-strength filament loops, each of the plurality of high-strength filament loops including a first end point and a second end point. The plurality of high-strength filament loops overlap each other at different angles.
[0056] Additionally or alternatively, the first and second endpoints of at least some of the plurality of high-strength filament loops may extend from a first edge of the repair implant to a second edge of the repair implant.
[0057] Additionally or alternatively, one or more of the first or second end points of at least one of the plurality of high-strength filament loops may be positioned a distance inward from an outer edge of the prosthetic implant.
[0058] Additionally or alternatively, each of the plurality of high-strength filament loops may be formed as a discrete loop.
[0059] Additionally or alternatively, multiple high-strength filament loops may be formed from a single, unitary filament.
[0060] Additionally or alternatively, multiple high-strength filament loops may be fused together at some of the intersection points of the overlapping loops.
[0061] A kind of composition is also described herein, it is combined with collagen to deliver calcium and / or phosphate ions, collagen is used as the support of new tissue formation and can be placed locally between soft tissue and bone, to promote the healing of soft tissue-bone interface. Composition can be pre-dried into flaky material and as preformed matrix, or as gel or slurry that solidifies in appropriate position to form matrix between soft tissue and bone and delivers. Composition of the present invention advantageously increases the generation of repair tissue at soft tissue bone interface, and thereby increases the recovery rate of the mechanical ability of healing tissue.
[0062] Examples of compositions of the present invention may include one or more of the following in any suitable combination.
[0063] In an example, a composition for soft tissue to bone repair of the present invention is composed of collagen, calcium compounds and phosphate compounds. The calcium compounds and phosphate compounds are evenly distributed throughout the composition. The composition forms a biocompatible matrix for insertion at the interface between soft tissue and bone and provides a stable mechanical environment for promoting the mineralization of tissue and / or bone. In an example, the composition is in the form of an injectable gel or slurry. In other examples, the composition is in the form of a dry sheet. In an example, the collagen is solubilized, pepsin-treated collagen. In an example, the calcium compound is calcium sulfate. In an example, the phosphate compound is sodium phosphate. In an example, the concentration of collagen in the composition is about 40 to 50 mg / ml. In an example, the concentration of calcium in the composition is about 5 weight % of the composition. In other examples, the concentration of calcium in the composition is about 10 weight % of the composition. In another example, the concentration of calcium in the composition is about 50 weight % of the composition.
[0064] An example of a method of manufacturing a composition for soft tissue to bone healing of the present invention includes preparing a first amount of a calcium compound and preparing a second amount of an aqueous sodium phosphate solution. A third amount of a collagen solution is added to the second amount of an aqueous sodium phosphate solution. The third amount of the collagen solution and the second amount of an aqueous sodium phosphate solution are mixed to a pH of about 6 to 7, so that the collagen solution is precipitated to form a collagen suspension. The collagen suspension is centrifuged until the volume of the collagen suspension is about 5 ml. Then, the collagen suspension is homogenized. After cooling, the first amount of the calcium compound is then added to the homogenized collagen suspension and mixed to form a composition of the present invention. The composition is in the form of an injectable gel or slurry.
[0065] In another example, the first amount of calcium compound is 34 mg. In other examples, the first amount of calcium compound is 86 mg. In other examples, the first amount of calcium compound is 340 mg. In an example, the collagen in the collagen solution is solubilized, pepsin-treated collagen. In an example, the second amount of sodium phosphate aqueous solution is about 2.84 ml. In an example, the third amount of collagen solution is 35 ml. In an example, the method also includes loading the composition into a syringe for injection at the soft tissue-bone interface of the patient. In other examples, the method also includes freeze-drying the composition into sheets for insertion at the soft tissue-bone interface of the patient.
[0066] An example of a method of attaching soft tissue to bone of the present invention includes performing surgical repair at a soft tissue-bone interface site of a patient; and injecting a gel or slurry containing a composition at the interface site. The composition consists of collagen, a calcium compound, and a phosphate compound. The calcium compound and the phosphate compound are evenly distributed throughout the composition. In other examples, the method includes performing surgical repair at a soft tissue-bone interface site of a patient; and inserting a dry sheet containing the composition at the interface site. The composition consists of collagen, a calcium compound, and a phosphate compound. The calcium compound and the phosphate compound are evenly distributed throughout the composition.
[0067] An example method of repairing damaged tissue in a joint having a bursa includes draining synovial fluid from the bursa; securing a sheet implant over the damaged tissue; and adding synovial fluid to the sheet implant.
[0068] Additionally or alternatively, the damaged tissue is a tendon.
[0069] Additionally or alternatively, the joint is a shoulder.
[0070] Additionally or alternatively, synovial fluid is added to the sheet implant prior to securing the sheet implant over the damaged tissue.
[0071] Additionally or alternatively, synovial fluid is added to the sheet-like implant after the sheet-like implant is secured over the damaged tissue.
[0072] Additionally or alternatively, the implant is dried and adding synovial fluid to the implant includes rehydrating the dried implant in synovial fluid prior to securing the implant over the damaged tissue.
[0073] Additionally or alternatively, adding synovial fluid to the implant includes injecting synovial fluid beneath the implant after securing the implant over the damaged tissue.
[0074] Additionally or alternatively, the implant is hydrated, and adding synovial fluid to the implant includes injecting synovial fluid into the hydrated implant.
[0075] Additionally or alternatively, the sheet-like implant comprises a first component comprising the biological layer, and a second component comprising a synthetic material, the first side surface of the second component being arranged on the first component.
[0076] Additionally or alternatively, the composite material comprises a plurality of pores.
[0077] Additionally or alternatively, the first component comprises collagen.
[0078] Additionally or alternatively, the method further comprises low molecular weight collagen disposed within the pores of the second component.
[0079] The above summary of some examples and embodiments is not intended to describe each disclosed embodiment or every implementation of the present invention. The following description of the drawings and detailed description more particularly exemplify these embodiments, but are also intended to be illustrative rather than limiting. BRIEF DESCRIPTION OF THE DRAWINGS
[0080] Figure 1 is a schematic front perspective view of a portion of a human shoulder;
[0081] Figure 2 It is a simplified stereoscopic view of the human rotator cuff and related anatomical structures;
[0082] Figure 3 yes Figure 2 Schematic diagram of a full-thickness tear of the supraspinatus tendon in the rotator cuff;
[0083] Figure 4 is a front view showing the upper torso of the patient with the left shoulder shown in cross-section;
[0084] Figure 5 is an enlarged cross-sectional view showing Figure 4 The left shoulder depicted in;
[0085] Figure 6 is an enlarged schematic cross-sectional view of a shoulder showing a partial tear and an exemplary repair implant positioned thereon;
[0086] Figure 7 is a schematic posterior stereoscopic view of an illustrative superior capsule reconstruction;
[0087] Figure 8 is a schematic anterior stereoscopic view of the hip joint;
[0088] Fig. 9 is a schematic anterior perspective view of a hip joint including a hip joint capsule;
[0089] Fig.10 is a schematic anterior stereoscopic view of a hip joint including multiple ligaments;
[0090] Fig.11 is a schematic side view of the hip joint including several hip muscles;
[0091] Fig.12 is a schematic perspective view of an illustrative prosthetic implant;
[0092] Fig.13A is a top view of illustrative structural layers of an illustrative prosthetic implant;
[0093] Fig. 13B yes Fig. 13B A bottom view of an illustrative structural layer;
[0094] Fig.14 is a top view of another illustrative structural layer of an illustrative prosthetic implant;
[0095] Fig.15 is a top view of another illustrative structural layer of an illustrative prosthetic implant;
[0096] Fig.16 is a top view of another illustrative structural layer of an illustrative prosthetic implant;
[0097] Fig.17A is a top view of another illustrative structural layer of an illustrative prosthetic implant;
[0098] Fig. 17B is a top view of another illustrative structural layer of an illustrative prosthetic implant;
[0099] Fig.18 is a top view of another illustrative structural layer of an illustrative prosthetic implant;
[0100] Fig.19A is a top view of another illustrative structural layer of an illustrative prosthetic implant;
[0101] Fig.19B is a top view of another illustrative structural layer of an illustrative prosthetic implant;
[0102] Fig. 20 is a schematic perspective view of another illustrative prosthetic implant;
[0103] Fig.21 is a top view of another illustrative prosthetic implant; and
[0104] Fig. 22 is a graph showing the results of a mineralization assay of the composition of the present invention using the Mc3T3 preosteoblast cell line.
[0105] Although the present invention is suitable for various modifications and alternative forms, its specific details have been shown in the drawings by way of example and will be described in more detail. However, it should be understood that it is not intended to limit the present invention to the specific embodiments described. On the contrary, it is intended to cover all modifications, equivalents and substitutes that fall within the spirit and scope of the present invention. DETAILED DESCRIPTION
[0106] The following description should be read with reference to the accompanying drawings, which are not necessarily drawn to scale, in which like reference numerals in the several views indicate like elements. The detailed description and the accompanying drawings are intended to illustrate, not to limit, the claimed invention. Those skilled in the art will recognize that the various elements described and / or shown may be arranged in various combinations and configurations without departing from the scope of the present invention. The detailed description and the accompanying drawings illustrate example embodiments of the claimed invention.
[0107] Definitions for certain terms are provided below and shall apply unless a different definition is given in the claims or elsewhere in this specification.
[0108] All numerical values are assumed to be modified by the term "about" herein, whether or not explicitly indicated. The term "about" generally refers to a numerical range that is considered by those skilled in the art to be equivalent to the quoted value (i.e., having the same or substantially the same function or result). In many instances, the term "about" may include numbers rounded to the nearest significant figure. As used herein, unless otherwise specified or inferred, the term "about" refers to a variation of ±10% from the nominal value. Unless otherwise specified, the term "about" (i.e., in a context other than a numerical value) may be assumed to have its common and customary definition, as understood and consistent with the context of this specification.
[0109] The recitation of numerical ranges by endpoints includes all numbers within that range (e.g., 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5). The description is specifically intended to include every individual subcombination of the members of such groups and ranges, as well as any combination of the various endpoints of such groups or ranges.
[0110] As used in this specification and the appended claims, the singular forms "a," "an," and "the" include or otherwise refer to singular as well as plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term "or" is generally intended to include "and / or" unless the content clearly dictates otherwise.
[0111] It should be understood that the expression "at least one" includes each of the listed objects following the expression, as well as various combinations of two or more of the listed objects, unless otherwise understood from the context and usage. The use of the terms "comprising", "having", or "including", including their grammatical equivalents, should generally be understood to be open-ended and non-restrictive, e.g., not excluding additional unlisted elements or steps, unless otherwise specifically stated or understood from the context.
[0112] The use of any and all examples or exemplary language herein, for example, "such as," "including," or "for example," is intended only to better illustrate the present teachings and is not intended to limit the scope of the present invention unless otherwise claimed. No language in the specification should be construed as indicating that any unclaimed element is essential to the practice of the present teachings. As used herein, "patient" refers to a mammal, such as a human.
[0113] It should be noted that references in the specification to "one embodiment", "some embodiments", "other embodiments", etc. indicate that the described embodiments may include a particular feature, structure, or characteristic, but each embodiment may not necessarily include the particular feature, structure, or characteristic. In addition, such phrases do not necessarily refer to the same embodiment. In addition, when a particular feature, structure, or characteristic is described in conjunction with one embodiment, whether or not explicitly described, it is within the knowledge of those skilled in the art to implement such feature, structure, or characteristic in conjunction with other embodiments, unless explicitly stated to the contrary. That is, even if not explicitly shown in a particular combination, the various individual elements described below are still considered to be combinable with each other or capable of being arranged with each other to form other additional embodiments or to supplement and / or enrich the described embodiments, as will be understood by those of ordinary skill in the art.
[0114] As used herein, "compound" refers to the compound itself and its pharmaceutically acceptable salts, hydrates and esters and biological variants, unless otherwise understood from the context of the specification or expressly limited to a specific form of the compound, i.e., the compound itself or its pharmaceutically acceptable salts, hydrates or esters.
[0115] In the case where an element or component is referred to as being included in a list of enumerated elements or components and / or being selected therefrom, it should be understood that an element or component may be any one of the enumerated elements or components, or an element or component may be selected from a group consisting of two or more of the enumerated elements or components. In addition, it should be understood that, without departing from the spirit and scope of this teaching, the elements and / or features of the compositions, equipment or methods described herein may be combined in various ways, whether expressly or implicitly in this article. It should be understood that the order of steps or the order in which certain actions are performed is insignificant, as long as this teaching remains operable. In addition, two or more steps or actions may be performed simultaneously.
[0116] The present invention relates generally to tissue repair implants.The tissue repair implant or repair implant may be a structural soft tissue repair implant for use with tissues such as, but not limited to, tendons and ligaments.
[0117] Figure 1 is a schematic front stereoscopic view of a shoulder 1 with some of the tendons, muscles, blood vessels, nerves, and bursae removed. The shoulder 1 may include additional structural components that are not explicitly shown and / or described. The present invention is not intended to provide complete anatomical details of the shoulder 1, but rather to provide an overview. Four joints make up the shoulder 1. These include the glenohumeral joint (not explicitly shown), in which the ball of the humerus 14 fits into a shallow socket of the scapula 12; the acromioclavicular (AC) joint 2, in which the clavicle 9 interfaces with the acromion 3 (which is part of the scapula 12); the sternoclavicular (SC) joint (not explicitly shown), which supports the connection of the arm and shoulder to the main frame at the chest; and the scapulothoracic joint (not explicitly shown), which is a pseudo-joint where the scapula 12 slides over the thorax (not explicitly shown).
[0118] The shoulder 1 also includes a number of ligaments that connect bones to bones. For example, the joint capsule 4 is a set of ligaments (not explicitly shown) that connect the humerus 14 to the glenoid cavity. The joint capsule 4 is an impermeable cavity that surrounds the glenohumeral joint and provides the primary source of stability to the shoulder 1. For example, the joint capsule 4 helps prevent the shoulder 1 from dislocating. The coracoclavicular ligament 5 connects the clavicle 9 to the scapula 12. The AC joint 2 connects the clavicle 9 to the scapula 12. Another ligament, the coracoacromial ligament 6 attaches the acromion 3 to the coracoid process 7 (which is part of the scapula 12).
[0119] In some cases, a rotator cuff tear may not be repairable. An alternative technique for direct rotator cuff repair is superior capsule reconstruction (SCR), which utilizes the above-described biological tissue scaffold to stabilize the joint by attaching the glenoid directly to the humeral head. For example, a scaffold, such as but not limited to the repair implant described herein, can be attached directly to the glenoid and humeral head to help restore the position of the shoulder 1, as described with respect to Figure 7 Shown in more detail. The brace may additionally be attached to the adjacent rotator cuff tissue.
[0120] Additional references Figure 2 (and as disclosed by Ball et al. in U.S. Patent Publication No. 2008 / 0188936), the rotator cuff 10 is a complex of four muscles arising from the scapula 12 and whose tendons fuse with the underlying joint capsule 4 as they attach to the tuberosity of the humerus 14. The subscapularis 16 arises from the anterior view of the scapula 12 and attaches above the greater tuberosity. The supraspinatus 18 arises from the supraspinatus fossa of the posterior scapula 12, passes below the acromion 3 and acromioclavicular joint 2, and attaches to the superior view of the greater tuberosity 11. The infraspinatus 13 arises from the infraspinatus fossa of the posterior scapula and attaches to the posterolateral view of the greater tuberosity 11. The teres minor 15 arises from the inferior lateral view of the scapula 12 and attaches to the inferior view of the greater tuberosity 11. The proper functioning of the rotator cuff 10 depends on the essential centering and stabilizing effect of the humeral head 17 relative to the sliding motion during forward and lateral lifting and rotational movements of the arm.
[0121] These tendons insert as a continuous rotator cuff 10 around the humeral head 17 allowing the rotator cuff muscles to provide an infinitely variable moment to rotate the humerus 14 and counter the unwanted components of the forces of the deltoid and pectoralis muscles. The insertion of the infraspinatus 13 overlaps to some extent with the insertion of the supraspinatus 18. Each of the other tendons 16, 15 also interweaves its fibers to some extent with its neighboring tendons. The tendons flare outward and cross each other to form a common continuous insertion on the humerus 14.
[0122] The rotator cuff muscles 10 are key elements of the shoulder muscle balance equation. The human shoulder does not have a fixed axis. In a given position, the activation of the muscles creates a unique set of rotational torques. For example, the anterior deltoid can apply torque in forward lifting, internal rotation, and cross-body movement. If forward lifting is to occur without rotation, the cross-body and internal rotation torques of this muscle must be neutralized by other muscles, such as the posterior deltoid and infraspinatus. The timing and amplitude of the action of these balancing muscles must be precisely coordinated to avoid unnecessary humeral motion directions. Therefore, the simplified view of muscles as isolated motors or as components of force must give way to an understanding that all the muscles of the shoulder work together in a precisely coordinated manner (e.g., the opposing muscles offset the unnecessary elements, leaving only the net torque that produces the required operation). Any injury to these soft tissues will greatly inhibit the range and type of motion of the arm.
[0123] The mechanics of the rotator cuff 10 are complex. The rotator cuff muscles 10 rotate the humerus 14 relative to the scapula 12, compress the humeral head 17 into the glenoid fossa (called concave compression) which provides a critical stabilizing mechanism for the shoulder and provide muscle balance. The supraspinatus and infraspinatus provide 45% of the abduction and 90% of the external rotation force. The supraspinatus and deltoid are also responsible for generating torque around the shoulder joint in the functional plane of motion.
[0124] Due to its complexity, range of motion, and widespread use, a fairly common soft tissue injury is that of the rotator cuff or rotator cuff tendons. A rotator cuff injury is a potentially serious condition that can occur with hyperextension, acute traumatic tear, or overuse of the joint. Due to its critical role in abduction, rotational strength, and torque production, the most common injury associated with the rotator cuff area is a strain or tear involving the supraspinatus tendon. Figure 3 A tear of the supraspinatus tendon 19 is schematically depicted in FIG. A tear at the tendon's insertion site on the humerus may result in the tendon separating from the bone. This separation may be partial or complete, depending on the severity of the injury. Additionally, the strain or tear may occur within the tendon itself. Injuries to the supraspinatus tendon and accepted treatment modalities are defined by the type and extent of the tear. The first type of tear is a full thickness tear, which is also Figure 3 As the term indicates, this tear extends through the thickness of the supraspinatus tendon, regardless of the width of the tear. The second type of tear is a partial thickness tear, which is further classified based on how much of the thickness is torn, regardless of whether it is greater or less than 50% of the thickness.
[0125] Accepted treatment for full thickness tears or partial thickness tears greater than 50% includes reattaching the torn tendon to the humeral head using sutures. For partial thickness tears greater than 50%, the tear is typically completed to a full thickness tear by cutting the tendon before reattaching the tendon. In treating full thickness tears or partial thickness tears greater than 50% after the tear is completed by cutting the tendon, accepted practice may also include placing a scaffold and patch over the repaired tendon to protect the sutured or repaired tendon area from anatomical loading during the healing period. For example, Ruiyi Medical discloses It can be used to reinforce suture-repaired tendons in large and giant full-thickness tears or smaller full-thickness tears in the shoulder with severely degenerated tissue. However, it should be recognized that overprotecting the tendon from loads can lead to atrophy and degeneration of the native tendon.
[0126] Figure 4 is a stylized front view of patient 28. For illustration purposes, Figure 4 2 shows a shoulder 26 of a patient 28 in cross section. The shoulder 26 includes a humerus 24 and a scapula 12. The movement of the humerus 24 relative to the scapula 23 is controlled by the muscles of the rotator cuff, as previously described with respect to Figure 2 For the sake of illustration, Figure 4 Only the supraspinatus muscle 30 is shown. Figure 4 It should be understood that the distal tendon 22 of the supraspinatus muscle 30 (hereinafter referred to as the supraspinatus tendon) intersects the humerus 24 at the insertion point 32.
[0127] Figure 5 FIG. 2 is an enlarged cross-sectional view of the shoulder 26 shown in the previous figure. Figure 5 , the head 36 of the humerus 24 is shown mating with the glenoid socket of the scapula 23 at the glenohumeral joint 38. The glenoid socket comprises a shallow depression in the scapula 23. Figure 5 Also shown are the supraspinatus 30 and deltoid 34. These muscles (among others) control the movement of the humerus 24 relative to the scapula 23. The distal tendon 22 of the supraspinatus 30 intersects the humerus 24 at the insertion point 32. Figure 5 In the embodiment of the present invention, the tendon 22 includes a damaged portion 40 located near the insertion point 32. The damaged portion 40 includes a tear 42 that extends partially through the tendon 22. The tear 42 can be referred to as a partial thickness tear. The depicted partial thickness tear is on the bursa side of the tendon; however, the tear can be on the opposite side or the joint side of the tendon, or can include an internal tear of the tendon that is not visible on either surface. Figure 5 The tendon 22 has been worn out. Figure 5 Some loose tendon fibers can be seen in the 44.
[0128] The scapula 23 includes an acromion 21. Figure 5 , the subacromial bursa 20 is shown extending between the acromion 21 of the scapula 23 and the head 36 of the humerus 24. Figure 5 In the figure, the subacromial bursa 20 is shown covering the supraspinatus 30. The subacromial bursa 20 is one of more than 150 bursae found in the human body. Each bursa includes a fluid-filled sac cavity. The presence of these bursae in the human body reduces friction between body tissues.
[0129] Figure 6 FIG. 2 is another cross-sectional view of the shoulder 26 shown in the previous figure. Figure 6 In the embodiment of the present invention, the tissue repair implant 25 has been placed above the partial thickness tear 42. Although the repair implant 25 has been described as being placed above the tendon, it should be understood that the repair implant 25 can be used to connect bone to bone. In addition, although the tear 42 is shown as a partial thickness tear, it should be understood that the implant 25 can also be used to repair full thickness tears. For example, the implant 25 can be used to reinforce a repair that is fully approximated or to bridge between the tendon and the bone when the tendon cannot be approximated back to the bone. Other repair scenarios may include, but are not limited to, use with a full thickness tear that has been repaired by reapproximating the torn tendon to the humeral head with sutures. In this case, the implant 25 can be placed on the bursal surface of the repaired tendon. In the embodiment shown, the repair implant 25 is placed on the bursal side of the tendon regardless of whether the tear is on the bursal side, on the articular side, or within the tendon. In addition, the repair implant can cover multiple tears, such as Figure 6The tearing on the joint side is also shown in . The implants disclosed herein can provide additional tensile strength while maintaining the ability of the implant 25 or a portion of the implant 25 to sometimes be completely absorbed and remodeled by the body.
[0130] In addition to the rotator cuff, the repair implant 25 can be used with other body tissues such as, but not limited to, the superior joint capsule (e.g., as in the SCR), the hip capsule, the gluteus medius tendon, the gluteus minimus tendon, the Achilles tendon, etc., which can benefit from the use of the repair implant 25. Figure 7 It is a schematic partial posterior stereogram of shoulder 1, wherein repair implant 25 is used in the reconstruction of upper joint capsule. As mentioned above, the repair implant 25 described herein can be directly attached to glenoid 8 and humeral head 17 to help restore the position of shoulder 1. The repair implant 25 can be additionally attached or sutured to (not explicitly shown) adjacent rotator cuff tissues, such as supraspinatus 18 and / or supraspinatus tendon 19. It should be noted that, although not explicitly shown, the repair implant 25 is fixed to glenoid 8 and humeral head 17 using appropriate bone anchors and sutures.
[0131] Figure 8 1 is a schematic front stereogram of a hip joint 100 with tendons, ligaments, muscles, blood vessels, nerves and bursae removed. The hip joint 100, pelvis 102 and / or femur 104 may include additional structural components that are not explicitly shown and / or described. The present invention is not intended to provide complete anatomical details of the hip joint 100, but rather to provide an overview. The hip joint 100 is a synovial ball-and-socket joint that connects the pelvis 102 and the femur 104. The hip joint 100 is very stable, in contrast to the shoulder, which is very flexible but not as stable as the hip joint 100. The proximal end of the femur 104 includes a femoral head 106, a femoral neck 108, a greater trochanter 110 and a lesser trochanter 112. The femoral head 106 is seated in an acetabulum 114, which is a circular depression in the pelvis 102. Both the socket portion (not explicitly shown) of the acetabulum 114 and the femoral head 106 include articular cartilage 116 disposed on their surfaces. The articular cartilage 116 allows the bones 102, 104 of the joint 100 to slide against each other without being damaged. Additionally, the articular cartilage 116 absorbs shock and provides a smooth surface to make movement easier. Ligaments (not explicitly shown) attach the femoral head 106 to the acetabulum 114. There is a small artery within the round ligament that provides some blood to the femoral head 106.
[0132] Fig. 91 is a schematic front stereogram of a hip joint 100 including a hip joint capsule 118. The joint capsule 118 is a watertight sac cavity that surrounds the joint 100 and connects the pelvis 102 and the femur 104. The joint capsule 118 can have a thickness in the range of about 1.3 mm to about 7 mm. However, it is conceivable that in a diseased hip, the thickness of the joint capsule 118 may be greater. The joint capsule 118 is attached to the pelvis 102 on the edge of the acetabulum 114, the transverse ligament (not explicitly shown), and is located above the boundary edge of the acetabular notch (not explicitly shown) and the obturator foramen 120. The hip joint capsule 118 is attached to the femur 104 in front of the intertrochanteric line 122, which extends between the greater trochanter 110 and the lesser trochanter 112 and behind the intertrochanteric crest (not explicitly shown). Hip capsule 118 comprises a group of strong ligaments, and it provides the main source of stability of joint 100 and keeps femoral head 106 in the appropriate position in acetabulum 114. Due to the force that it bears in various hip motion ranges, hip capsule 118 part is high strength. The main blood supply for femoral head 106 comes from the blood vessels running under hip capsule 118. Hip capsule 118 is conventionally cut, so as to perform arthroscopic hip surgery. At the end of hip arthroscopy, it is expected to repair hip capsule 118. When repairing hip capsule 118, it is expected to ensure that the previously cut section heals again. In some cases, joint capsule tissue 118 may be substantially degenerated, or there is not enough hip capsule 118 to create enough structural recovery. This may be due to partial joint capsule removal (intentional or unintentional), or it is expected to have more hip flexibility, and patients who repair native joint capsule will result in hips with more difficult range of motion (e.g., patients, such as butterfly goalkeepers or ballet dancers). It may be desirable to place a repair implant over the repaired joint capsule to protect the sutured or repaired area from excessive loading during the healing period.
[0133] Fig.10 1 is a schematic anterior stereogram of a hip joint 100, which includes a plurality of ligaments that reinforce the hip joint capsule 118. These ligaments include the iliofemoral ligament 124, the pubofemoral ligament 126, and the ischiofemoral ligament (not explicitly shown). The iliofemoral ligament 124 is substantially "Y" shaped. The iliofemoral ligament 124 is attached to the pelvis 102 between the anterior inferior iliac spine (not explicitly shown) and the edge of the acetabulum 114, and is attached to the femur 104 at the intertrochanteric line 122. The pubofemoral ligament 126 is between the pelvis 102 and the femur 104 at the iliopectineal protuberance of the pelvis 102. The ischiofemoral ligament is located posteriorly and extends between the ischium (not explicitly shown) of the pelvis 102 and the greater trochanter 110 of the femur 104.
[0134] Fig.111 is a schematic side view of a hip joint 100 including multiple hip muscles. These muscles include gluteus minimus 128, gluteus medius 130 and gluteus maximus 132. Gluteus minimus 128, gluteus medius 130 and gluteus maximus 132 can allow extension of the leg and abduction of the leg. In some cases, partial thickness or full thickness gluteal tear may occur in the tendons 134, 136, 138 connecting muscles 128, 130, 134 to femur 104. These tears may eventually lead to hip abduction weakness and gait abnormalities, which are sometimes referred to as Trendelenburg gait. In some cases, gluteal tendon tear is caused by wear and tear tendinopathy that may be similar to rotator cuff tear. In some cases, these tears can be treated with non-surgical procedures, including but not limited to activity modification, anti-inflammatory treatment, physical therapy, etc. Other hip pain may also be attributed to gluteal tendons. For example, stubborn lateral hip pain, also known as greater trochanteric pain syndrome, may have lesions of the gluteus medius and gluteus minimus tendons. These tears and lesions of the hip abductor tendon can be repaired endoscopically. However, the failure rate of the repair may be as high as 35%. A repair implant may be placed over the repaired gluteal tendon to protect the sutured or repaired area from excessive loading during the rehabilitation period.
[0135] The hip includes additional muscles, tendons, ligaments, blood vessels, nerves, and bursae that are not explicitly shown. For example, the hip includes the following muscles that are not explicitly shown: the iliotibial band, adductor muscles, iliopsoas muscles, rectus femoris, sartorius muscles, external rotators, and hamstrings. These muscles, in conjunction with the hip muscles 128, 130, 132, allow for abduction, adduction, flexion, extension, internal rotation, and lateral rotation of the leg. Abduction, adduction, flexion, and extension can be combined to produce circumduction.
[0136] In some embodiments, a repair implant is designed to provide a combination of structural features, properties and functions that can be used to treat partial or full-thickness tears of the rotator cuff and / or gluteal tendons 134, 136, 138 and / or repair the hip capsule 118. Although the repair implant is described with respect to specific conditions and scenarios of the shoulder and hip, it should be understood that the repair implant described herein can be used in other conditions or scenarios where it is desired to encourage tissue ingrowth while also providing additional mechanical properties, such as, but not limited to, strength and stiffness. These features, properties and functions may include: rapid deployment and fixation through an arthroscopic approach that complements current procedures; load-stretching properties that result in an ideal sharing of anatomical loads between the implant and the native tendon during rehabilitation; selected porosity and longitudinal paths for tissue ingrowth; sufficient cyclic tensioning of the implant with new tissue ingrowth; inducing a healing response; and in some cases, the repair implant is bioresorbable or otherwise resorbable so that additional loads are transferred to the native tendon over time.
[0137] Fig.12 2 is a schematic perspective view of an illustrative tissue repair implant 200. Although the repair implant 200 is shown as having a generally rectangular morphology, other shapes may also be used as desired. The repair implant 200 may be a multilayer hybrid scaffold comprising a first or biological layer 202 and a second or structural layer 204. Although the repair implant 200 is shown as having two layers, it is contemplated that the repair implant 200 may also include any number of layers required, such as but not limited to one, two, three, four or more. Typically, the structural layer 204 has mechanical properties, such as strength, stiffness, creep, suture pull-out, etc., to support the load on the repair implant 200 at the time of initial implantation, while the biological layer 202 (e.g., collagen) provides rapid tissue ingrowth. The sheet structure 200 is defined by a longitudinal dimension L, a transverse dimension W, and a thickness T. In some embodiments, the transverse and longitudinal dimensions of the repair implant 200 may range from about 20 millimeters (mm) to 50 mm in the transverse W and 25 mm to 50 mm in the longitudinal L. The thickness T of the sheet structure can be about 0.5 mm to 5 mm when dehydrated. It is contemplated that the thickness of the implant 200 can be thicker, in the range of about 1 mm to 10 mm, when dehydrated. When implanted, the longitudinal dimension L can be generally in the load-bearing direction of the tendon or parallel thereto. For example, in Figure 6 In the embodiment shown, the longitudinal direction L follows the supraspinatus tendon from its origin in the supraspinatus muscle down to its attachment area on the humerus. As is understood in the art, when the supraspinatus muscle contracts, the load on the tendon is in this general direction.
[0138] While some previous implants may promote rapid tissue ingrowth (e.g., blood vessels and fibroblasts), previous implants may not provide any additional strength to the damaged tendon until new tissue is induced. In some cases, it may be desirable to provide a repair implant 200 that provides immediate mechanical strength to the tendon and also induces a healing response. This can be achieved via a layered or composite implant 200. The implant 200 may include a first layer or component 202 having a first set of properties and a second layer or component 204 having a second set of properties. In some cases, the first layer 202 may be a bio-inductive implant or component including a biological component such as, but not limited to collagen, and the second layer 204 may be a higher strength component formed from a synthetic material or a natural material structured for higher strength. While Fig.12A single biolayer 202 is shown, but it is contemplated that a second biolayer 202 may be positioned on an opposite side of the structural layer 204 such that the structural layer 204 is positioned between (e.g., sandwiched between) the two biolayers 202. More than two layers 202, 204 may have similar thicknesses, or different thicknesses as desired.
[0139] The layers 202, 204 can be attached or joined using a variety of techniques, including, but not limited to, mechanical joining (e.g., suturing, braiding) and / or chemical joining. In some cases, the layers 202, 204 can be attached to each other in a sutured manner using medical grade fibers to sew the layers together. Alternatively or additionally, in some cases, the biological component 202 and the higher strength component 204 can be formed as a laminate structure. For example, the biological component 202 and the higher strength component 204 can be formed as discrete layers, such as Fig.12 As shown. In other cases, implant 200 can include a transition zone between layers 202, 204 so that biological part 202 and higher strength component 204 are mixed in the transition zone. In other embodiments, biological component 202 and higher strength component 204 can be an integrated composite material (e.g., a single layer with biological and synthetic aspects). For example, higher strength component 204 can be dispersed throughout biological component 202. Biological component 202 and higher strength component 204 can have different tensile moduli and tensile strengths that are different from each other. For example, biological component 202 can have a performance that encourages tissue ingrowth or healing response, and higher strength component 204 can have a performance that provides immediate mechanical strength, as will be discussed in more detail below.
[0140] The biological component 202 can be a recombinant collagen made from high-purity type 1 collagen derived from bovine tendon. However, other collagen sources can also be used. The collagen fibers can be processed so that the biological component 202 extends into and / or around the structural layer 204. In some embodiments, the biological layer 202 can have a grid structure, which can be 3D printed in a flat 2-dimensional pattern or a 3-dimensional pattern according to the 3D printing technology utilized, as described in more detail herein. Although 3D printing is an illustrative example, other suitable manufacturing techniques can also be used as needed. For example, the grid structure and / or other structures described herein can be formed by molding, which can be perforated, woven, etc. to form a desired arrangement. The biological layer 202 can be porous or include a path that encourages tissue to grow inward. In some embodiments, the sheet structure of the biological component 202 includes a material that defines a plurality of holes that encourage tissue to grow therein. In some embodiments, if so provided, the size and / or spacing of the holes and / or paths can be varied or changed based on the grid structure. In some cases, the size, spacing, and / or orientation of the holes and / or pathways may be selected to encourage tissue growth in a particular orientation. Porosity and tissue ingrowth allow the new collagen to integrate with the collagen of the native tendon to achieve functional load bearing.
[0141] It should be understood that the sheet structure may include various pore-defining structures without departing from the spirit and scope of the present specification. In some embodiments, the sheet structure has a pore size in the range of about 20 to about 400 microns. In some embodiments, the pore size is in the range of about 100 microns to about 300 microns, and in some embodiments, it is about 150 to about 200 microns. The porosity can be about 30% to about 90%, or it can be in the range of at least about 50% to about 80%. In some cases, the biological component can have a porosity of about 0.2 grams per cubic centimeter (g / cm 3 ) to 0.4g / cm 3 The dry density of the fiber can be within the range of . Examples of pore-defining structures are discussed in more detail below for specific embodiments, and examples may include, but are not limited to, open-cell foam structures, reticular structures, micro-machined hierarchical structures, and structures comprising a plurality of fibers. In some embodiments, the fibers may be interconnected to one another. Various processes may be used to interconnect the fibers to one another. Examples of processes that may be suitable for use in some applications include weaving, knitting, crocheting, and plaiting.
[0142] It is contemplated that the initial tensile modulus of the biological component 202 may be less than the tensile modulus of the supraspinatus tendon, which is in the range of 50 MPa to 150 MPa. In some cases, some hip ligaments and / or tendons may have a tensile modulus in the range of about 4 MPa to about 22 MPa. Other hip ligaments and / or tendons may have a tensile modulus of about 24 MPa to about 25 MPa. The iliofemoral ligament 124 may have a tensile modulus in the range of about 76 MPa to about 286 MPa at 80% strain or a tensile modulus of about 1 to about 3.3 MPa at about 0% strain. For example, the biological component 202 may be designed to have a tensile modulus in the range of 5 MPa to 50 MPa. In some embodiments, the tensile modulus may be about 10 MPa.
[0143] In some cases, it is desirable to generate as much tissue as possible under anatomical constraints. In some cases of tendon degeneration or partial tearing, the load on the tendon is relatively low during the early weeks of rehabilitation. For example, in the shoulder, the load may be about 100N. During rehabilitation, the strain in the tendon caused by the load may be about 2%. In some of these cases, the biological component 202 can be designed to have an initial ultimate tensile strength of at least about 2MPa. The tensile strength can be designed to be no more than about 50MPa and no less than about 5MPa, wherein the failure load is about 50N to 100N. The compression modulus can be designed to be at least about 0.2MPa. Similarly, the pull-out strength of the suture can be relatively low. For example, the pull-out strength of the suture can be in the range of 5N to 15N. It should be understood that the biological layer 202 can be designed to have an initial ultimate tensile strength, tensile strength, failure load, compression modulus, suture pull-out strength, etc., to be used in body areas outside the shoulder.
[0144] The biological component 202 can be configured to allow loading and retention of biological growth factors. The biological component 202 and / or the growth factors can be configured to controllably release the growth factors. The biological component 202 can be configured to allow for the transport of body fluids to remove any degradation byproducts and potential elution profiles of the biological agent. The biological component 202 can also include platelet-rich plasma or other biological factors at the time of implantation to promote healing and tissue formation.
[0145] The second or higher strength component 204 can generally be stronger than the first component 202, thereby having a higher initial tensile strength and a higher initial tensile modulus than the first component 202. For example, the second component 204 can have a tensile strength approximately equal to the tensile strength of the supraspinatus tendon, which may be in the range of 20MPa to 30MPa. In other uses, such as but not limited to the hip capsule, the gluteal tendon, the Achilles tendon, etc., the second component 204 can be designed to have a tensile strength approximately equal to the tendon at the implant position. The tensile strength of the second component 204 can be four to five times greater than the tensile strength of the biological component. In some cases, the second component 204 can have a failure load in the range of about 200N or greater, 300N or greater, 400N or greater, 500N or greater.
[0146] In order to achieve the desired degree of load sharing, the initial tensile modulus of the second component 204 should be in the same approximate range as the tensile modulus of the tendon. For example, for the case of being used in the rotator cuff, the second component 204 can have a tensile modulus in the range of 50MPa to 150MPa. This can allow the initial load on the implant 200 to be in the range of 50% or more. It is conceivable that when used to repair the rotator cuff, the implant 200 may need to bear a load in the range of 20N to 80N during rehabilitation. The rehabilitation load of hip capsule repair may be similar to the load of rotator cuff repair. It is conceivable that the repair implant used in some repair scenarios (such as but not limited to SCR) needs to bear a load after the rehabilitation period, and requires a larger failure load, such as a failure load in the range of about 200N or greater, 300N or greater, 400N or greater, 500N or greater.
[0147] The suture pull-out strength of the second component 204 can be higher than the suture pull-out strength of the first component 202. For example, the suture pull-out strength of all combined sutures needs to be sufficient to support the load under the worst-case scenario (for example, attaching the implant to both bone and tendon). As mentioned above, for the situation used in the rotator cuff, the implant 200 may need to carry a load of up to 80N during the early rehabilitation period. During normal use, the implant 200 may need to carry a load of 140N or more. If four sutures are used to attach the implant 200, each suture will need a pull-out strength in the range of about 35N or more. In some cases, the suture can have a pull-out strength of 100N or more. It is conceivable that the pull-out strength of the suture can be increased by chemically bonding and / or sewing together the first component 202 and the second component 204 around its periphery cross-linked.
[0148] The load requirement for repairing implant 200 may change according to the tendon to be repaired, ligament or other soft tissue.For example, the load requirement associated with "irreparable" rotator cuff tear (for example, when the tendon is retracted very far, so that it can not be reattached to the humeral head, wherein the implant must be bridged in the gap between the tendon and the humeral head) or when SCR is needed, it may be larger than partial tear repair.It is conceivable that when repairing implant 200 is used to bridge the gap between the tendon and the humeral head or when SCR is needed (these are only some examples), repairing implant 200 can carry load infinitely.For example, in these cases, repairing implant 200 will not transfer load to the tendon repaired.
[0149] In one example, the second component 204 can be designed to provide stress protection until the rotator cuff tendon of repair is reattached to the humeral head. In other examples, the second component 204 can be designed to provide stress protection until the hip capsule, buttocks tendon, Achilles tendon or other damaged tissues heal. This may occur in a time period of 3 to 6 months. Therefore, the second component 204 can maintain its strength for at least 3 to 6 months, and in some cases, can be kept longer and then begin biodegradation. The second component 204 may include one or more bioabsorbable materials. The example of bioabsorbable materials that may be applicable to some applications includes those in the following list, but this is not exhaustive: polylactic acid (PLA), poly-L-lactic acid (PLLA), poly-D-lactic acid (PDLA), polyglycolide (PGA), PGA / PLA blends, polydioxanone, polycaprolactone, polygluconate, polylactic acid-polyethylene oxide copolymer, modified cellulose, collagen, poly-(hydroxybutyric acid), polyanhydride, polyphosphate, poly-(amino acid), poly-(alpha-hydroxy acid) or related copolymer materials. In some embodiments, the hydrothermal conversion temperature can be selected to provide the required absorption time. It is conceivable that the second component 204 can be absorbed more slowly than the biological component 202. For example, the second component 204 can be completely absorbed in about one year. This is just an example. In some cases, the second component 204 can be formed by a non-bioabsorbable material. For example, the second component 204 can be formed by non-absorbable polyester, high-toughness polyester, polytetrafluoroethylene (PTFE), polyetheretherketone (PEEK), nylon or ultra-high molecular weight (UHMW) polyethylene. The material of the selected second component 204 should be high purity and have good biocompatibility to avoid adverse inflammatory reactions. In other embodiments, the second component 204 can be formed by a combination or mixture of absorbable and non-absorbable materials. In some cases, the surface of the structural layer 204 can be chemically modified, and a connecting compound is applied thereto so that the structural layer 204 is covalently or ionically bonded to the biological layer 202.
[0150] The surface treatment can vary depending on the material forming the second component 204. For example, UHMW polyethylene can be pretreated with air plasma to form unstable hydroperoxides on its surface. Then, the surface can be modified with acrylic acid and / or itaconic acid. Then, in the presence of a water-soluble carbodiimide / hydroxysuccinimide crosslinking system, the second component 204 is covalently bonded to between the amino groups on the biological component 202 and the carboxyl groups on the modified surface of the second component 204. Alternatively, the UHMW polyethylene can be pretreated with ammonia plasma. The pretreated UHMW polyethylene can react with dimethyl suberimide. Next, the modified UHMW polyethylene can react with a collagen dispersion buffered from a pH value of about 3.5 to about 9, which will result in collagen precipitation. The modified UHMW polyethylene can be left in the collagen solution to allow the collagen to react with the modified UHMW polyethylene. In another example, polyester (PET) can be surface modified with sodium borohydride to reduce the carbonyl group to an alcohol. Next, a transesterification reaction can be performed with methyl phenylcarbamate. The surface-modified PET can then be reacted with dimethyl suberimidate. Next, the modified PET can be reacted with a collagen dispersion that has been buffered at a pH of from about 3.5 to about 9, which will result in collagen precipitation. The modified PET can be left in the collagen solution to allow the collagen to react with the modified PET. It is also contemplated that a coating for assisting biological tissue attachment and integration, such as, but not limited to, a collagen coating, can be applied to the surface of the second component 204. In yet another example, cross-linking of the second component 204 to the biological layer 202 can be accomplished with formaldehyde.
[0151] The structural layer 204 may include holes and / or pathways to allow for tissue ingrowth. Fig.13A is a front view of an illustrative knitted structural layer 204, and Fig. 13B yes Fig.13A 204 is a rear view of an illustrative knitted structural layer. Fig.13A and 13B The structural layer 204 shown in FIG. 1 can be formed by knitting one or more filaments or strands 206 into a weft knitted fabric. In a weft knitted fabric, a single yarn can form a loop that runs in the weft direction 214. In some cases, the knitting "stitch" can be selected to provide loops 208, 210 that include a plurality of openings 216. In some cases, the loops 208, 210 can extend in different directions. For example, when observing the front portion ( Fig.13A ), the ring 208 extends parallel to the first direction 212. When observing the rear portion ( Fig. 13B), the loop 210 extends parallel to a second direction 214 that is substantially perpendicular to the first direction 212. Additional loops 218 extending in a third direction 219 (e.g., substantially orthogonal to the plane of the structural layer 204) may be provided. These loops 218 may provide attachment points for the biological layer 202 to attach to it. This may help prevent or minimize delamination of the structural layer 204 from the biological layer 202. It is contemplated that other knitting stitches or weaving patterns may be used to form the structural layer 204. For example, if the repair implant 200 is cut, a tear-resistant pattern in the edge or throughout the structural layer 204 may be used to prevent unraveling. In addition, the tear-resistant pattern may provide a fixing point that may minimize sutures that pull through the edge of the repair implant 200.
[0152] Fig.14 is a front view of another illustrative knitted structural layer 203. Fig.14 The structural layer 203 shown in the figure can be formed by knitting one or more filaments or strands 205 into a warp knitted fabric. In some cases, knitting "stitches" can be selected to provide loops 207, 209 extending in a generally vertical direction 212 (e.g., warp) and including a plurality of openings 211. In some cases, loops 207, 209 can be angled (e.g., zigzag) in different directions. Additional loops (not explicitly shown) extending in a third direction (e.g., generally orthogonal to the plane of the structural layer 204) can be provided. These loops can provide attachment points for the biological layer 202 to be attached thereto. This can help prevent or minimize the delamination of the structural layer 204 and the biological layer 202. It is conceivable that other knitting stitches or weaving patterns can be used to form the structural layer 204. For example, if the repair implant 200 is cut, tear-resistant patterns (e.g., vertical strands, herringbone patterns, etc.) can be used to prevent unraveling. Additionally, the tear-resistant pattern may provide securement points that may minimize comb-out from the repair implant 200 .
[0153] It is contemplated that other methods of forming a porous structure or fabric may also be used. For example, two or more filaments or strands may be woven together. It is contemplated that the size of the opening may be varied by varying the tightness with which the strands are woven. In another example, the structural layer may be formed using a non-woven or non-knitted technique. In such an example, staple fibers or staple fibers may be used to form the base structure. The base structure may be randomly oriented to a certain extent, with the fibers primarily aligned in a first or "Y" direction, and some fibers extending in a second or "X" direction and some extending in a third or "Z" direction. In some cases, the alignment of the fibers may be broken by piercing the fabric with a hook needle and retracting the needle to allow some fibers to pass through to the back side. The porosity of such a non-woven fabric may be manipulated by varying the fiber density. In some cases, the porosity may be in the range of 90% or greater.
[0154] In some cases, knitted, crocheted, woven, and / or non-woven fabrics can be formed using a mix of techniques (e.g., non-homogeneous). For example, a border and / or one or more edges can be formed by a different knit stitch, weave, etc. than the center of component 204. In some cases, a knitted support can have a woven border. This is just one example. Those skilled in the art will recognize that there are any number of possible combinations. It is also contemplated that biological component 202 can be formed using any of the knitting, weaving, and / or non-woven techniques described herein.
[0155] It is also contemplated that other structures or configurations may be used to introduce porosity into structural layer 204 as desired. Fig.15 A schematic top view of a structural layer 220 is shown, which has a structure different from that of the structural layer 204. The structural layer 220 can be used in the repair implant 200 to replace the structural layer 204 or as a supplement thereof. The structural layer 220 can include a substantially solid synthetic layer 222 having one or more mechanically introduced holes 224. For example, the substantially solid synthetic layer 222 can be a polymer sheet or a dense fiber. The hole 224 can be cut, molded, stamped, etc. into the synthetic layer 222. In some cases, the structural layer 220 can be formed to have some flexibility. For example, the structural layer 220 can be a flexible structure composed of nitinol, other thin metal structures (e.g., titanium alloys, such as Ti6Al4V or stainless steel 300 series), flexible polymers, such as but not limited to UHMWPE or polysaccharides with a crimping pattern, to allow the repair implant 200 to expand in a hydrated state, and to compensate for the tension of the biological layer 202 during the placement of the repair implant 200. Although the holes 224 in the figures are shown as having substantially equal or uniform spacing, it is contemplated that the holes 224 may be eccentrically spaced if desired. For example, the size, number, configuration and / or shape of the holes 224 may be varied to achieve desired tissue ingrowth.
[0156] In some cases, low molecular weight and / or low viscosity collagen can be applied within the openings 216 or holes 224 of the structural layers 204, 220. The presence of collagen within the structural layers 204, 220 can also promote tissue ingrowth. Then, the biological layer 202 including higher molecular weight collagen can be deposited on the structural layers 204, 220.
[0157] In some embodiments, the structural layer 204 of the repair implant 200 can be replaced with a collagen layer, which includes a mesh structure designed to have the required mechanical properties, such as strength, stiffness, creep, suture pull-out, etc., to support the load on the repair implant 200 during initial implantation. The mesh structure can be a patterned, symmetrical or asymmetrical distribution of collagen lines or filaments. As required, the mesh structure can include a single layer or multiple layers of lines or filaments. In one example, two to three (or more) biological layers 202 of type 1 collagen can be laminated together. One of those layers (e.g., replacing the structural layer 204) can be a structural mesh made of dense collagen lines or filaments, which can be 3D printed in various patterns to fine-tune structural properties. Other layers of 80% porous collagen fibers (e.g., biological layers 202) will be applied to the structural mesh layer on either or both sides for initial tissue ingrowth. This can provide additional tensile strength for the repair implant 200 while maintaining its ability to be fully absorbed and reshaped by the body. Additionally, the structural mesh layer can be designed to have a specific elastic modulus that best supports the remodeling of the newly formed tendon-like tissue. Further, in some cases, the structural mesh layer can be designed to have an elastic upper limit (e.g., a degree of stretchability) where after the repair implant 200 has been stretched a certain amount, the fibers are designed in a way so that the now straight structural cords provide a high degree of strength and stiffness, which can help the newly formed tissue not experience excessive stretching and possible damage (such as, but not limited to, not about Fig.18 , Fig.19A and Fig.19B Embodiments shown and described herein). For example, the structural fibers can be oriented approximately obliquely to the direction of the load. Thus, when a load is applied and the mesh is stretched, the fibers can straighten (e.g., in the direction of the load) so that they structurally withstand the force. As a result, the material will be stiffer and will not stretch beyond a desired threshold.
[0158] It is contemplated that the structural mesh layer may be 3D printed in a planar 2-dimensional pattern or a 3-dimensional pattern depending on the 3D printing technology utilized. For example, extruder-based 3D printing may be best suited for 2-dimensional pattern creation of the structural mesh layer, which will then be laminated with highly porous type 1 collagen for tissue ingrowth. While 3D printing is an illustrative example, other suitable manufacturing methods may also be used as desired.
[0159] In one example, type 1 collagen is extruded from a small nozzle in the form of a thick slurry, which controls the diameter of the filaments or ropes deposited on a flat dry platform. The nozzle of the extruder is digitally controlled by a computer to extrude in a 2-dimensional pattern. The printer can then adjust the height of the nozzle away from the platform and print additional layers on top of the previously printed layer to create a 3-dimensional structure, as will be described in more detail herein. The liquid or slurry collagen can then be freeze-dried or subjected to other acceptable drying methods (such as, but not limited to, air drying or oven drying) to maintain the printed structure so that it can be transferred to another process in which low-density, high-porosity collagen is applied to the structural grid by spraying.
[0160] In another example, type 1 collagen is extruded as a thick slurry from a small nozzle that controls the diameter of a filament or rope that is deposited in a gelatinous vat that has enough density to keep the extruded material suspended in space and not sink to the bottom of the vat. Suspending the printing material within the gel allows for the creation of geometries in 3D space that do not require support structures to be printed along with the desired structure. Support structures are temporary and removed in post-processing, and generally limit the types of geometries that can be 3D printed.
[0161] In yet another example, stereolithography (SLA) can be used. In SLA, type 1 collagen is in liquid form, and the energy from the laser solidifies or cross-links a specific point. The laser point moves to create a solid pattern. This may involve post-processing, where uncured liquid is removed from the solid printed structure, and the final solid printed structure needs to undergo additional curing stages to bring it to full strength.
[0162] Fig.16A schematic top view of an illustrative structural layer with a mesh structure 250 is shown, which can be formed with collagen, but also enhances the structural performance of the repair implant 200. The mesh structure 250 can be formed by extruded lines of highly dense collagen in a thick gel-like state using a solvent as a suspension during extrusion. The solvent evaporates and leaves a solid rope of collagen. The diameter of the rope can be customized for a specific target strength. The mesh structure 250 may include one or more boundary or perimeter lines 252. The boundary line 252 can be formed as a single spiral rope or multiple interconnected ropes as desired. It is also conceivable that the mesh structure 250 may include any number of boundary lines 252 required, such as, but not limited to, one, two, three, four or more. It is conceivable that the boundary line 252 can be designed or structured for a specific application (e.g., a specific anatomical location) to strengthen the area where the tendon anchor and / or bone anchor is fixed, which can provide increased tear resistance.
[0163] A cross diamond pattern 254 can be created within the boundary line 252 for the grid structure 250. In some cases, the diamond pattern 254 can be formed as a single, uninterrupted continuous line. In other cases, the diamond pattern 254 is formed by a plurality of interconnected lines or ropes 266. The diamond pattern 254 can also include a plurality of loops 258, which couple the diamond pattern to the boundary line 252. When the diamond pattern 254 is formed by an uninterrupted continuous line, a plurality of loops 258 can be a part of the continuous line. When the slurry is extruded, the extruder can apply pressure at a specific time to press the lines together to form adhesion points 256. The diamond pattern 254 can have a certain flexibility in orthogonal directions 260, 262, and has a certain rigidity in diagonal directions 263, 265. The pattern or arrangement of the grid structure 250 can be changed to adjust the strength of the repair implant 200 to adapt to a specific anatomical structure. For example, the diamond pattern 254 does not need to be symmetrical or evenly arranged. It is contemplated that the thickness of the cords 266, the spacing of the cords 266 (e.g., density), etc. are just some of the parameters that can be adjusted to achieve a mesh structure 250 with desired structural properties. For example, the spacing of the diamond pattern 254 can be changed to form smaller or larger openings. The slope of the cords 266 that form the diamond pattern 254 can also be changed to change the angle of the intersection 256. For example, the intersection 256 can include non-orthogonal angles. These are just some examples of how the strength or other structural features of the mesh structure 250 can be manipulated.
[0164] Fig.17AA schematic top view of an illustrative structural layer having a lattice structure 270 is shown, which lattice structure 250 can be formed with collagen, but also enhances the structural performance of the repair implant 200. The lattice structure 270 can be formed by extruded strands of highly dense collagen in a thick gel-like state using a solvent as a suspension when extruded. The solvent evaporates and leaves behind a solid rope of collagen. The diameter of the rope can be customized for a specific target strength. The lattice structure 270 can be formed by a plurality of cross-hatched ropes 272, 274. A first plurality of ropes 272 can extend in a first direction 276, and a second plurality of ropes 274 can extend in a second direction 278 that is substantially perpendicular to the first direction 276. It is contemplated that when the repair implant 200 is implanted in the body, the ropes 272, 274 can be aligned to extend in a specific orientation. For example, when used to repair a rotator cuff, one set of ropes can extend in a medial-lateral direction, while another set of ropes can extend in an anterior-posterior direction (when looking at the rotator cuff). However, it should be understood that the implantation orientation of the tethers 272, 274 may vary based on the anatomy being repaired.
[0165] When extruding the paste, the extruder can apply pressure at specific times to press the strands together to form adhesion points 280. In some cases, the cords 272, 274 can be manipulated while being extruded to form a basket weave or generally woven configuration (e.g., in an alternating over / under arrangement).
[0166] exist Fig.17A In the illustrative embodiment of FIG. 2 , the cords 272, 274 may be arranged uniformly in the first direction 276 and the second direction 278. However, this is not required. The cords 272, 274 may be arranged in any desired pattern or arrangement. In some cases, the mesh structure 270 may include a pattern in which more cords or fibers are extruded in one direction than in another direction. For example, Fig. 17B An alternative grid structure 270' is shown, wherein there are more ropes 272 extending in a first direction 278 than ropes 274 extending in a second direction 278. This particular configuration can provide higher strength in a first direction 276 relative to a second direction 278. The pattern of the grid structure 270 can be changed to adjust the strength of the repair implant 200 to accommodate a specific anatomical structure. For example, the arrangement of ropes 272, 274 can be asymmetric. It is contemplated that the thickness of ropes 274, the spacing (e.g., density) of ropes 274, and the number of ropes 272, 274 are only some of the parameters that can be adjusted to achieve a grid structure 270 with desired structural performance. It is also contemplated that ropes 272, 274 can extend at non-orthogonal angles relative to each other. In some cases, one or more peripheral ropes can also be provided.
[0167] Fig.18 A schematic top view of an illustrative structural layer having a lattice structure 300 is shown, which lattice structure 300 can be formed with collagen but also enhances the structural properties of the repair implant 200. The lattice structure 300 can be formed from extruded strands of highly dense collagen in a thick gel-like state using a solvent as a suspension when extruded. The solvent evaporates and leaves behind solid ropes 302, 304 of collagen. The diameter of the ropes 302, 304 can be tailored for a specific target strength. The lattice structure 300 can have a diameter greater than 100 mm. Fig.13A , 13B and 14 structures deeper depth. For example, the grid structure 300 can be formed by superimposing two patterns. The first group of ropes 302 can be used to form the first or lower pattern. In the illustrated embodiment, the three ropes 302 of the first group 306a are extruded side by side in a zigzag or wavy pattern. The three ropes 302 of the second group 306b are extruded side by side and laterally spaced apart from the first group 306a in a zigzag or wavy pattern similar to the first group 306a. The three ropes 302 of the third group are extruded side by side and laterally spaced apart from the second group 306a in a zigzag or wavy pattern similar to the second group 306a. Groups 306a, 306b, 306c (collectively referred to as 306) form the lower pattern together. It is conceivable that the lower pattern may include any number of groups 306 required, such as, but not limited to, one, two, three, four or more. In addition, each group 306 may include any number of ropes 302 required, such as, but not limited to, one, two, three, four or more. It is contemplated that each set 306 need not have the same number of cords 302. Although the sets 306 are shown forming a zigzag pattern, other patterns or configurations may be used as desired.
[0168] Once the lower pattern has been extruded, the upper pattern can be extruded thereon. The second group of ropes 304 can be used to form the second or upper pattern. In the illustrated embodiment, the three ropes 304 of the first group 308a are extruded side by side in a zigzag or wavy pattern, which superimposes a part of the first group 306a of the lower pattern and a part of the second group 306b. The first group 308a of the upper pattern can be superimposed with a part of the first group 306a of the lower pattern at one or more intersections 310. Similarly, the first group 308a of the upper pattern can be superimposed with a part of the second group 306a of the lower pattern at one or more intersections 312. The three ropes 304 of the second group 308b are extruded side by side and spaced apart laterally with the zigzag or wavy pattern similar to the first group 308a. The second group 308c can be superimposed with a part of the second group 306b of the lower pattern and a part of the third group 306c. For example, the second group 308b of the upper pattern can overlap with a portion of the second group 306b of the lower pattern at one or more intersections 314. Similarly, the second group 308b of the upper pattern can overlap with a portion of the third group 306c of the lower pattern at one or more intersections 316. The upper pattern can be pressed into the lower pattern at each of the intersections 310, 312, 314, 316 to form a joint or combined joint. When the upper pattern is arranged above the lower pattern, the grid structure 300 can have a diamond pattern. Groups 308a, 308b (collectively referred to as 308) form the upper pattern together. It is conceivable that the upper pattern can include any number of groups 308 required, such as, but not limited to, one, two, three, four or more. In addition, each group 308 can include any number of ropes 304 required, such as, but not limited to, one, two, three, four or more. It is conceivable that each group 308 does not need to have the same number of ropes 304. Although groups 308 are shown as forming a zigzag pattern, other patterns or configurations may be used as desired.
[0169] The pattern of the mesh structure 300 can be changed to adjust the strength of the repair implant 200 to accommodate a particular anatomical structure. For example, the arrangement of the cords 302, 304 can be asymmetrical. It is contemplated that the thickness of the cords 302, 304, the spacing (e.g., density) of the cords 302, 304 or their groups 306, 308, the number of cords 302, 304, the number of groups 306, 308 are just some of the parameters that can be adjusted to achieve a mesh structure 300 with desired structural performance. In some cases, one or more peripheral cords may also be provided.
[0170] Fig.19AA schematic top view of an illustrative structural layer having a grid structure 320 is shown which can be formed with collagen but also enhances the structural properties of the repair implant 200. The grid structure 320 can be formed from extruded strands of highly dense collagen in a thick gel-like state using a solvent as a suspension when extruded. The solvent evaporates and leaves behind solid ropes 322 of collagen. The diameter of the ropes 322 can be customized for a specific target strength. The grid structure 320 can be formed from a plurality of circles 326 that are joined or bonded 324 together in a side-by-side arrangement. The circular pattern can create uniform elasticity in all directions. It is contemplated that the spacing of the circles 326 can be changed or varied to manipulate the structural properties of the grid structure 300. For example, as Fig.19A As shown, the circles 326 may be positioned so that they are in contact with adjacent circles 326. In other embodiments, at least some of the circles 326 may be spaced apart from adjacent circles. Fig.19B A mesh structure 320' is shown in which circles 326 touch adjacent circles 326 in a first direction 328, but are laterally spaced apart from adjacent circles 326 in a second direction 330. It is contemplated that the laterally spaced apart circles 326 may be joined or connected by one or more linear cords 332. Increasing the spacing between circles 326 may alter the structural properties of the mesh structure 300', as well as increase the area for tissue ingrowth.
[0171] The pattern of the mesh structure 320, 320' can be changed to adjust the strength of the repair implant 200 to accommodate a particular anatomical structure. For example, the arrangement of the linear cords 322 and / or circles 326 can be asymmetrical. It is contemplated that the thickness of the cords 322, the spacing (e.g., density) of the cords 322, the number of cords 322, the shape of the circles 326 (e.g., shapes other than circular) are just some of the parameters that can be adjusted to achieve a mesh structure 320 with desired structural properties. In some cases, one or more peripheral cords may also be provided.
[0172] In some embodiments, the mesh structures 250, 270, 270', 300, 320, 320' can be formed of materials other than collagen. For example, any of the mesh structures 250, 270, 270', 300, 320, 320' can be formed as a molded portion of an absorbable material, such as PLA and a highly porous collagen fiber mesh is applied to one or both sides of the mesh structure 250, 270, 270', 300, 320, 320' to form one or more biological layers 202. It is contemplated that injection molding the mesh structures 250, 270, 270', 300, 320, 320' (and / or other structural layers described herein) can provide the advantage of high repeatability and control over the shape of the mesh as well as the diameter of each cord and the strength of each joint between cords. Further advantages may include, but are not limited to, high scalability and perhaps easier control during the manufacturing process of applying highly porous collagen to one or both sides of the structural mesh.
[0173] Fig. 20 4 is a schematic perspective view of an illustrative tissue repair implant 400. The sheet structure 400 is defined by a longitudinal dimension 412, a transverse dimension 414, and a thickness 410. In some embodiments, the transverse and longitudinal dimensions of the repair implant 400 may range from about 20 millimeters (mm) to 50 mm in the transverse direction 414, and from 25 mm to 50 mm in the longitudinal direction 412. The thickness 410 of the sheet structure may be about 0.5 mm to 5 mm when dehydrated. It is conceivable that the thickness of the implant 400 may be thicker, in the range of about 1 mm to 10 mm, when dehydrated. When implanted, the longitudinal dimension 412 may be roughly in the load-bearing direction of the tendon or parallel to it. Although the repair implant 400 is shown as having a substantially rectangular cross-sectional shape, other cross-sectional shapes may also be used as desired, such as, but not limited to, square, circular, elliptical, polygonal, triangular, etc. It is also conceivable that the overall dimensions (e.g., longitudinal dimension 412, transverse dimension 414, and / or thickness 410) may be changed to accommodate a particular application.
[0174] The repair implant 400 may include a bioinductive scaffold 402, which may be similar in form and function to the biolayer 202 described herein. Fig. 20The reinforcing structure can be used in combination with or in place of any of the structural layers described herein. As described above, the bioinductive stent 402 itself may not be able to withstand the load applied thereto. Strands 404a, 404b, 404c (collectively referred to as 404) can be woven into the bioinductive stent 402 as a reinforcing structure. Strands 404 can be formed by dermal tissue strands, sutures or other biocompatible materials. If provided in this way, the sutures can be absorbable types, non-absorbable types or combinations thereof. Other materials can be used to replace or supplement dermal tissue strands or sutures. Examples of bioabsorbable materials that may be suitable for use in some applications include those in the following list, which is not exhaustive: polysaccharides, polylactic acid, poly-L-lactic acid (PLLA), poly-D-lactic acid (PDLA), polyglycolide (PGA), polydioxanone, polycaprolactone, polygluconate, polylactic acid-polyethylene oxide copolymers, modified cellulose, collagen, poly(hydroxybutyric acid), polyanhydrides, polyphosphates, poly(amino acids), poly(alpha-hydroxy acids), or related copolymer materials. Examples of non-absorbable materials that may be suitable for use in some applications include those in the following list, which is not exhaustive: non-absorbable polyesters or ultra-high molecular weight (UHMW) polyethylene.
[0175] The strands 404 can be interwoven into the bioinductive scaffold 402 in a variety of braiding and / or suture patterns. For example, any number of suture configurations can be imagined that will strengthen the material (different number of rows, orientations, suture patterns, cross-over geometries, etc.) and provide specific mechanical properties (e.g., tensile strength, etc.) to the bioinductive scaffold 402. In some cases, the strands 404 can have loops, spiral arrangements, a row of spiral strands, zigzag arrangements, or other sinusoidal patterns. The example shown is just one of many possible patterns. It is also conceivable that strands 404 with different thicknesses can also be used. In some cases, the geometry of the strands 404 and / or the pattern of the sutures can vary over the width and / or length of the bioinductive scaffold 402. In some cases, the strands 404 can be provided as a preformed arrangement that can be attached to the bioinductive scaffold 402 by a clinician.
[0176] In one example, some of the strands 404a can be interwoven so that they extend generally parallel to the longitudinal dimension 412. The strands 404a can extend through the entire thickness 410 of the bioinductive scaffold 402 (e.g., such that the strands 404a are visible on opposite sides of the bioinductive scaffold 402) or can extend partially through the thickness 410 of the bioinductive scaffold 402 (e.g., such that the strands 404a are not visible on opposite sides of the bioinductive scaffold 402). It is contemplated that the strands 404a can be interwoven in a single row or multiple rows (e.g., Fig. 20402). It is contemplated that the number of sutures in each row may also vary. For example, if more than one row is provided, each row may have the same number of sutures or a different number of sutures as desired. In some cases, the length of the sutures (e.g., in the longitudinal dimension 412) may vary. It is contemplated that decreasing the length of the sutures while increasing the number of sutures may increase the strength of the repair implant 400. In some cases, the color of the strands 404 (e.g., sutures) may be distinguished from the color of the bioinductive stent 402 to facilitate stent placement. For example, this color distinction may provide a visualization aid to the surgeon.
[0177] Alternatively or additionally, some of the strands 404b can be interwoven such that they extend generally parallel to the transverse dimension 414. The strands 404b can extend through the entire thickness 410 of the bioinductive scaffold 402 (e.g., such that the strands 404b are visible on opposite sides of the bioinductive scaffold 402) or can extend partially through the thickness 410 of the bioinductive scaffold 402 (e.g., such that the strands 404b are not visible on opposite sides of the bioinductive scaffold 402). It is contemplated that the strands 404b can be interwoven in a single row or multiple rows (e.g., Fig. 20 414). It is contemplated that the number of sutures in each row may also vary. For example, if more than one row is provided, each row may have the same number of sutures or a different number of sutures as desired. In some cases, the length of the sutures (e.g., in transverse dimension 414) may vary. It is contemplated that decreasing the length of the sutures while increasing the number of sutures may increase the strength of the repair implant 400.
[0178] Although the strands 404a, 404b are described as extending generally orthogonal to one another (and parallel to the dimensions of the bioinductive scaffold 402), it is also contemplated that other orientations may be used. For example, one or both of the strands 404a, 404b may extend at non-parallel and / or non-orthogonal angles to one another and / or to the dimensions of the bioinductive scaffold 402. It is also contemplated that the strands may be interwoven in a single orientation (parallel, orthogonal, non-orthogonal, or other) relative to the dimensions of the bioinductive scaffold 402.
[0179] In some embodiments, some strands 404c can be positioned at the edge of the bioinductive scaffold 402. The strands 404c can form a loop that can be entered from a point outside the bioinductive scaffold 402. In other words, the strands 404c can be within the edge 406 of the bioinductive scaffold 402 or outside the edge 406, so that the strands 404c can be used to support the attachment to the native structure. In some cases, the strands 404 can also be used to transport or manipulate the bioinductive scaffold 402 for placement of the bioinductive scaffold 402. It is conceivable that the scaffold 404c can be positioned around the entire perimeter or border of the bioinductive scaffold 402 or only a portion thereof as desired. In addition, there can be any number of strands 404c required, such as, but not limited to, one, two, three, four or more.
[0180] Fig.21 502a, 502b, 502c, 502d, 502e, 502f (collectively 502) are a plurality of superimposed high strength filament loops. It should be noted that for the sake of simplicity, Fig.21 Each different ring is not individually identified in the figure. Each ring 502 can be formed by a line or filament. The ring 502 can be attached to each other by fusing or bonding each intersection 510 of the filaments forming the ring 502. This can be done using, for example, heat or adhesive. However, it is conceivable that not every intersection is to be fused. Each ring 502 can be formed as a continuous ring separately and then assembled into a repair implant 500. For example, the ring 502 can be laid on top of each other to form a repair implant 500 with different orientations (for example, angles relative to each other), rather than as a braided or knitted material. In some cases, when the ring 502 is positioned, the orientation of the subsequent ring 502 can change relative to the previously positioned ring 502, but this is not necessary. This configuration can carry tension between relative points 506a, 506b (collectively referred to as 506) around the repair implant 500. It should be noted that each ring 500 includes opposing points; however, for simplicity, specific markings have been made on the points 506a, 506b of a single ring 502b. Although not explicitly shown, in some cases, a ring 502 can be positioned so that it is generally aligned with a previously laid ring (either directly on top of it or with other rings 502 between them).
[0181] In some cases, suture anchors (not explicitly shown) can be positioned in the bone at the repair site, where the suture anchors roughly correspond to the opposite points 506 of one or more loops 502. Sutures 508a, 508b can be passed through the repair implant 500 at each of the points 506 (or a subset thereof) to secure the repair implant 500 in the body. If the sutures pass just through the filaments forming the loops 502, the elongation of the repair implant 500 may be very small. In some cases, the sutures can be tied together to form an air cushion stitch or they can be directly attached to the repair implant 500. It is contemplated that the repair implant 500 can share the shear load between all bone anchors.
[0182] Some rings 502a can extend roughly parallel to the length direction 504 of implant 500. Other rings 502b can extend roughly orthogonal to the length direction 504 of implant 500. Other rings 502c, 502d can extend at a non-vertical angle relative to the length direction 504 of implant 500. It is conceivable that the number of rings 502 extending in each direction can vary to achieve the desired structural performance. It is also conceivable that one or more rings 502e, 502f may not extend completely across the periphery of repair implant 500. For example, one or more ends of one or more rings 502e, 502f can be positioned inwardly at a distance from the periphery or outer edge of repair implant 500. Including rings 502e, 502f that do not extend from the edge of repair implant 500 to the edge can allow repair implant 500 to be cut (e.g., to match the desired anatomical structure) while maintaining the integrity for suture anchoring.
[0183] The repair implant 500 may include any number of rings 502 desired, such as, but not limited to, two or more, five or more, ten or more, twenty or more, etc. It is contemplated that the physical properties of the repair implant 500 may be altered by varying the number of rings 502. For example, fewer rings 502 may result in a thinner, more porous repair implant 500. Increasing the number of rings 502 may increase the thickness of the repair implant 500 (e.g., when the rings 502 are stacked) and result in a generally less porous structure. Although the rings 502 are described as individual and discrete structures, in some cases, the repair implant 500 may be comprised of a plurality of rings 502 that have been wrapped to achieve a similar Fig.21 The structure shown is formed as a continuous line or filament.
[0184] The stacked ring structure of the repair implant 500 can improve the footprint of soft tissue compression on bone by eliminating the biased stretch that may be seen in braided materials. It is also contemplated that sharing the shear and compression forces between several suture anchors will reduce individual detachment forces, thereby reducing suture detachment.
[0185] In other examples, bioactive materials can be added directly to any of the implants or scaffolds discussed herein during implantation. In some embodiments, synovial fluid can be added to the implant. The synovial fluid is rich in bioactive agents, including stem cell populations, growth factors, and recruitment factors, and contributes to the healing response of natural tendons. The fluid obtained from the bursa can be comparable to the stem cell population found in the bone marrow as a reservoir of bioactive recruitment factors and healing potential.
[0186] During the implantation procedure of any one of the implants or stents described herein, the bursectomy or other procedures of an anatomical joint (e.g., shoulder joint) can be performed to extract synovial fluid from the bursa of an anatomical joint. For example, synovial fluid, also referred to as synovial fluid, can be extracted from the bursal cavity of the bursa of an anatomical joint with a syringe. The extracted synovial fluid (i.e., the synovial fluid removed from the patient's body) can be subsequently transported back to the anatomical joint when the implant is implanted. In some cases, before the implant or stent is fixed above the damaged tissue (e.g., torn tendon) of the anatomical joint, the extracted synovial fluid can be added to the implant or stent. For example, the extracted synovial fluid can be used to fill a hydrated implant or stent, which can be made of collagen, and the extracted synovial fluid uses a large-caliber needle syringe. Because the synovial fluid comes from the patient, before the extracted synovial fluid is injected into the implant or stent, it is not necessary to process the synovial fluid. Once the synovial fluid has been applied to the implant or stent, the implant or stent can be inserted into the joint space and fixed to the damaged tissue. If desired, purified extracellular proteins may be added to the extracted synovial fluid and / or the implant during implantation of the implant.
[0187] In some embodiments, the implant may be hydrated in saline prior to delivery to the joint space. Another embodiment may involve hydrating the dehydrated implant in synovial fluid (such as synovial fluid extracted from a patient during a medical procedure) or other bioactive slurry obtained during a medical procedure prior to implanting the implant. In some examples, the synovial fluid or other bioactive slurry may be mixed with saline. Hydration of the implant in synovial fluid with a high concentration of slurry-suspended cellular material may require only a few minutes before cells can be expected to adhere to the synovial side of the collagen implant.
[0188] In other cases, after the implant is fixed over damaged tissue (e.g., a torn tendon), the extracted synovial fluid can be added to the implant. For example, after the implant is in place and fixed to the damaged tissue, the extracted synovial fluid can be injected below the implant.
[0189] Alternatively, the extracted synovial fluid can be mixed with a coagulating material (such as fibrin glue) and coated on both sides of the implant before fixing the implant against the damaged tissue. In another embodiment, the extracted synovial fluid can be injected into a biocompatible capsule cavity that is disposed below the implant when implanted above the damaged tissue. The biocompatible capsule cavity can be permeable to allow the liquid to seep onto the implant within a period of time (such as a period of days, weeks, or months) after the medical procedure.
[0190] One advantage provided by adding a biological factor, such as synovial fluid, is that it increases the chances of healing for patients with a tendency to poor healing, such as smokers or diabetics, by providing an additional form of recruitment. In addition, such modifications may allow for faster healing rates than an unmodified implant alone.
[0191] According to various aspects of the disclosure of this detailed description, a method for treating a tear or lesion of a tendon or ligament is also provided. In some methods, a supraspinatus tendon, hip capsular ligament, gluteal tendon and / or Achilles tendon with complete tear, partial thickness tear greater than 50% and / or partial thickness tear less than 50% or significant degeneration is treated. The treatment site in the damaged tendon area can be first entered through an arthroscopic approach. However, in some cases, an open technique can be used to enter the tendon. A repair implant such as the previously described repair implant can be placed above the partial tear of the tendon. In certain embodiments, an implant can be placed above a tendon with complete or partial tear, abrasion and / or inflammation. If left untreated, a slight or partial tendon tear may develop into a larger or complete tear. According to various aspects of the present invention, a complete or partial tear can be treated by protecting it with a repair implant as described above. This treatment can promote healing and provide instant strength to the tendon, as well as prevent more extensive damage to the tendon, thereby avoiding the need for more invasive surgery.
[0192] In order to deliver the repair implant through arthroscopy, the implant can be configured to be collapsible so that it can be inserted into a tubular member or be installed thereon to be inserted into the treatment site through arthroscopy. For example, the implant and the associated delivery device can collapse like an umbrella, and the delivery system of the deployment wherein unfolds the pleats of the implant when the implant is installed thereon, to allow surface-to-surface engagement with the tendon, without any substantial wrinkles. In some cases, once flush with the tendon, sutures or other suitable modes can be used, such as short fiber attachment repair implants, so that stretchability due to native tendon and implant experience the same strain under load, can ensure that anatomical loads are shared. In other cases, the repair implant can be attached using bone screws and sutures or other suitable modes so that the repair implant carries whole loads.
[0193] In summary, the repair implant can include an absorbable material, an absorbable material layer, a reinforced absorbable material and / or a combination of an absorbable material and a non-absorbable material. In certain embodiments, the purpose of the implant is to protect the injured portion of the tendon during healing, provide implants 200, 400 for the growth of new tissue and / or temporarily share the load of some tendons. The implant can induce the formation of additional tendon-like tissue, thereby increasing strength and reducing pain, micro-strain and inflammation. In certain embodiments, the implant can replace tissue that cannot be repaired. When implanted, implants 200, 400 can provide instant strength to the tendon and transfer the load to the native tendon as the tendon heals and the implants 200, 400 degrade. In other embodiments, the repair implant 200, 400 can carry all loads indefinitely. In certain embodiments, organized collagen fibers are created, which are reshaped into tendon-like tissue or new tendons with cell viability and vascularity. The initial hardness of the device may be lower than the hardness of the native tendon so that the fixation will not be overloaded when the tendon tissue is generated.
[0194] The materials used in the implant device should be able to withstand compression and shear loads consistent with the recognized postoperative movement of the implantation location (e.g., shoulder, hip, knee, ankle, etc.). The periphery of the device may have different mechanical properties from the inside of the device, such as to facilitate better retention of sutures, staples or other fastening mechanisms. Materials can be selected to be compatible with visual, radiographic, magnetic, ultrasonic or other common imaging techniques. The material may be able to absorb and retain growth factors, wherein a hydrophilic coating may be used to promote the retention of additives.
[0195] Further described herein are compositions intended for use as simple collagen matrices to transfer calcium ions (Ca +2 ) and / or phosphate ions (PO4 -3 ) is delivered to the interface between an injured tendon or ligament and bone to promote healing of the attachment to the bone. Collagen is selected as the delivery medium because it is biocompatible, biodegradable and can be in the form of an injectable gel or slurry with the ability to set and form a weak suspension or dry sheet. This advantageously allows Ca +2 and / or PO4 -3 Remaining in place at the interface and delivered locally, while providing a transient collagen scaffold for new tissue formation.
[0196] In an example, the composition of the present invention includes about 40 to 50 mg / ml of collagen (+ / - 10%), such as fibrous atelocollagen. In addition, a calcium compound, such as calcium sulfate (CaSO4) (which converts to about 4 to 20 mg / ml of CaSO4) is used during processing at a final percentage of anywhere from about 1 to 20%.+2 ), and a small amount of a phosphate compound, such as sodium phosphate (Na2HPO4) (0.5 to 0.01 molar final concentration range), so that the calcium and phosphate compounds are evenly distributed throughout the composition. Dissolved hydrogen phosphate (HPO4 -2 ) will easily react with some dissolved Ca +2 React to form calcium phosphate until there are no free phosphate ions. Dissolved sodium chloride (NaCl) is also present in the mixture. It should be understood that other calcium compounds, such as calcium phosphate, calcium carbonate, calcium nitrate and / or calcium chloride can also be used to form the composition of the present invention.
[0197] One example of a method of making an injectable gel form of the composition of the present invention will now be described.
[0198] Initially, the following amounts of CaSO4 were transferred into two glass weighing funnels for preparing a first example of a composition comprising a 5% concentration (by weight) of calcium ions and a second example of a composition comprising a 50% concentration (by weight) of calcium ions. Alternatively, a third example of a composition comprising a 10% concentration (by weight) of calcium ions may be prepared: Final calcium content in the composition <![CDATA[Mass of CaSO4]]> 5% by weight 34mg 10% by weight 86mg 50% weight 340mg Each funnel was placed in a 250 ml beaker and covered with aluminum foil. The covered beakers were placed in an oven and heated at 250° C. for at least one hour to sterilize the calcium compound. However, other known sterilization methods are also contemplated by the present invention.
[0199] Next, add about 80 ml of deionized water to a 100 ml volumetric flask, followed by about 3.55 g of Na2HPO4 to prepare a 0.25 M aqueous solution of Na2HPO4. Place the flask on a stir plate until the Na2HPO4 dissolves. Then, add deionized water to the 100 ml mark on the flask. Then mix the Na2HPO4 solution and check its volume.
[0200] Next, prepare a 50ml centrifuge tube and transfer 35ml of collagen solution to the tube. In an example, the collagen solution can be bovine solubilized, pepsin-treated collagen (atelo collagen). About 2.84ml of Na2HPO4 solution is added to the centrifuge tube containing 35ml of collagen solution. The tube is capped and mixed to a pH value of about 6 to 7, so that the collagen is precipitated to form a fibrous collagen suspension, which is white and opaque. Then, about 3.8ml of pH buffer solution, such as 10× Dulbecco's phosphate buffered saline (DPBS), is added to each test tube containing collagen, capped and mixed.
[0201] Centrifuge the collagen precipitate at 24,000 × g for approximately 4 minutes. After centrifugation, use the mark on the centrifuge tube to check the volume of collagen. The volume at the end of centrifugation should be approximately 5 ml, which corresponds to a target fibrillar collagen concentration of approximately 40 ± 5 mg / ml. Calculate the concentration of collagen according to the following equation: Where C is the collagen concentration and V is the volume. A factor of 0.95 means a 95% yield in the process.
[0202] If the concentration is too low, place the tube back into the centrifuge and centrifuge for another 5 minutes. If necessary, additional DPBS can also be used to adjust the target collagen concentration. The additional volume of DPBS to be added can be calculated using the following equation: The calculated amount of 10×DPBS can be added to an empty 30 ml syringe and connected to the syringe containing the collagen concentration using a Luer-to-Luer connector and mixed by passing the collagen concentration from syringe to syringe at least 30 times. When the target collagen concentration is reached, the supernatant is poured from the collagen suspension and the collagen suspension is homogenized using a high shear homogenizer. Then, 5 ml of the collagen suspension is transferred equally between two 10 ml syringes.
[0203] After the two beakers containing 34mg and 340mg of CaSO4 were cooled to room temperature, the two concentrations of CaSO4 were transferred to two separate clearly marked 10ml syringes. One of the 10ml syringes containing the collagen suspension was connected to the 10ml syringe containing 34mg of CaSO4 with a Luer connector, and mixed by transferring the collagen suspension from syringe to syringe at least 30 times. Another 10ml syringe containing the collagen suspension was connected to the 10ml syringe containing 340mg of CaSO4 with a Luer connector, and mixed by transferring the precipitate from syringe to syringe at least 30 times. The two final injectable collagen / Na2HPO4 / Ca +2 The gel compositions, one having 5% calcium by weight and the other having 50% calcium by weight, were filled into syringes for injectable use on patients.
[0204] One example of a method for producing a dry sheet of the composition of the present invention will now be described.
[0205] Initially, a suspension of collagen, Na2HPO4 and CaSO4 is generated, as described above, after adjusting the input amounts of the components to account for the increased volume and the desired sheet size and density. The suspension is poured onto a flat mold with raised edges that will define the dimensions of the sheet (length x width), including the desired thickness of the final dried sheet. The mold with the suspension is then placed into a freeze dryer and subsequently freeze dried to produce the final dried sheet.
[0206] In an example, the composition described herein can be used to enhance the surgical repair of tendon to bone, for example, rotator cuff repair. For example, the surgical repair of the attachment of the rotator cuff to the bone below can be performed according to standard, suture anchor-based technology. During the reattachment of the tendon to the bone, the injectable gel form of the composition can be introduced into the tendon-bone interface. For example, the injectable gel form of the composition can be injected onto the bone surface at the position of repair via a syringe or similar device before the reattachment of the tendon, but after the suture anchor is placed. In other examples, the dry sheet form of the composition can be placed on the bone surface at the position of repair before the reattachment of the tendon, and before or after the suture anchor is placed. In other examples, after the surgical repair is completed, the injectable gel form of the composition can be injected into the tendon-bone interface by means of a syringe and a needle passing through the interface between the tendon tissue and the tissue. In another example, the injectable gel form of the composition can be introduced into the central cannula of the open structure suture anchor via a modified sleeve suture anchor inserter during the anchor placement and before the tissue is re-approached. A non-limiting example of an open-structure suture anchor can be found in U.S. Pat. No. 8,894,661 to Smith & Nephew, Inc. (Memphis, Tennessee), the entire contents of which are incorporated herein by reference. A non-limiting example of a syringe can be found in International Publication No. WO 2017 / 213893 to Smith & Nephew, Inc. (Memphis, Tennessee), the entire contents of which are incorporated herein by reference.
[0207] In other examples, the compositions described herein can be used to enhance ligament repair, for example, anterior cruciate ligament (ACL) reconstruction. In an example, the surgical repair of a torn ACL is performed using a ligament graft according to standard surgical techniques. Then, a dry sheet is placed at the graft-bone junction in a bone tunnel for graft placement and fixation (by suspension fixation or using interference screws). In an example, a dry sheet can be wrapped around the ends of the graft, which will be placed in the bone tunnel during the preparation of the graft before the graft is introduced into the joint. Alternatively, the graft can be placed in the bone tunnel, and then the injectable gel form of the composition can be injected around the graft before being fixed using a syringe. Example
[0208] The composition of the present invention was evaluated in a cell-based system using a composition of the present invention having 0% by weight CaSO4, 5% by weight CaSO4 and 10% by weight CaSO4, respectively. MC3T3 preosteoblasts were cultured for 14 days using the three corresponding compositions. Cell-based experiments showed that the expression of bone mineralization markers (e.g., alkaline phosphatase designated as ALP) was increased in cells cultured on the composition compared to collagen alone, such as Figure 1 This indicates that the composition described herein enhances new bone formation by MC3T3 osteoblasts.
[0209] It should be understood that even though numerous characteristics of various embodiments have been set forth in the foregoing description, as well as details of the structure and function of the various embodiments, this detailed description is illustrative only and that variations may be made in the details, particularly in the aspects of the arrangement of structures and components shown by the various embodiments, to the maximum extent indicated by the broad general meaning of the terms used to express the appended claims. The scope of the invention is therefore indicated by the appended claims rather than the foregoing description, and all changes coming within the meaning and equivalency range of the claims are therefore intended to be embraced therein.
Claims
1. A repair implant comprising: a sheet-like first component, the sheet-like first component comprising a biological layer; as well as A reinforcement strand is interwoven into the first component.
2. The prosthetic implant of claim 1, wherein the biolayer is bioresorbable.
3. A prosthetic implant according to claim 1 or 2, wherein the reinforcing strands are a different colour than the first component.
4. The prosthetic implant of any one of claims 1 to 3, wherein the stitching pattern of the reinforcing strands changes geometry along the length and / or width of the prosthetic implant.
5. The prosthetic implant according to any one of claims 1 to 3, further comprising one or more rings within the edge of the sheet-like first component or outside the edge of the sheet-like component.
6. The prosthetic implant of claim 5, wherein the one or more rings are configured to support attachment of the prosthetic implant to a natural structure.
7. The prosthetic implant of any one of claims 1-3, wherein the reinforcing strands are interwoven in a direction extending generally parallel to and / or generally orthogonal to the longitudinal dimension of the sheet-like first component.
8. A repair implant comprising: a plurality of high-strength filament loops, each loop of the plurality of high-strength filament loops comprising a first end point and a second end point; The plurality of high-strength filament loops overlap each other at different angles.
9. The prosthetic implant of claim 8, wherein the first endpoint and the second endpoint of at least some of the plurality of high-strength filament loops extend from a first edge of the prosthetic implant to a second edge of the prosthetic implant.
10. The prosthetic implant of claim 8, wherein one or more of the first or second endpoints of at least one of the loops in the plurality of high-strength filament loops are positioned a distance inward from an outer edge of the prosthetic implant.
11. The prosthetic implant of any one of claims 8 to 10, wherein each of the plurality of high-strength filament loops is formed as a discrete loop.
12. A prosthetic implant according to any one of claims 8 to 10, wherein the plurality of high strength filament loops are fused together at some of the intersection points of the superimposed loops.
13. A prosthetic implant comprising: biolayer; as well as An extruded structural layer is disposed on the biological layer.
14. The prosthetic implant of claim 13, wherein the extruded structural layer comprises a plurality of cords.
15. The prosthetic implant of claim 14, wherein the extruded structural layer further comprises one or more peripheral cords.
16. The prosthetic implant of claim 15, wherein the extruded structural layer further comprises cords in a diamond pattern.
17. The prosthetic implant of claim 16, wherein the diamond patterned cord further comprises a plurality of loops.
18. The prosthetic implant of claim 17, wherein the plurality of loops connect the diamond pattern cord to the one or more peripheral cords, wherein the plurality of loops connect to the one or more peripheral cords via one or more adhesion points.
19. The prosthetic implant of claim 13 wherein the extruded structural layer comprises collagen.
20. The prosthetic implant of claim 13, wherein the biological layer comprises collagen.
